India Glycols Limited · NSE:INDIAGLYCO
India Glycols — Q2 & H1 FY2023-24 Earnings Presentation
35 slides from India Glycols's earnings presentation, Nov 6, 2023
Slide 1: Regulation 30 disclosure letter to stock exchanges
6th November, 2023 The Manager (Listing) The Manager (Listing) BSE Limited National Stock Exchange of India Limited 1st Floor, New Trading Ring, Exchange Plaza, C-1, Block G, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Dalal Street, Bandra (East), Mumbai – 400 001 Mumbai- 400 051 Scrip Code
Slide 2: Investor Presentation Q2 & H1 FY 2023-24
India Glycols Limited v v v Investor Presentation Q2 & H1 FY 2023-24 1
Slide 3: Safe Harbour Statement
Safe Harbour Statement This presentation and the following discussion may contain “forward looking statements” by India Glycols Limited (“IGL” or the company) that are not historical in nature. These forward-looking statements, which may include statements relating to future results of operations, f
Slide 4: Q2 & H1 FY24 Performance
Q2 & H1 FY24 Performance INDIA GLYCOLS LIMITED
Slide 5: Performance Overview Q2FY24 vs Q2FY23
Performance Overview Q2FY24 vs Q2FY23 Gross Turnover EBITDA PAT 1,871 Cr 105 Cr 38 Cr + 4.5 % +43.4 % +61.2% Net Turnover EBITDA Margin PAT Margin 775 Cr 13.5% 4.8% +15.7% +257 bps +135 bps ⦁ Witnessed overall a strong quarter with the healthy improvement in revenue and profitability ⦁ Margins also
Slide 6: Performance Overview H1FY24 vs H1FY23
Performance Overview H1FY24 vs H1FY23 Gross Turnover EBITDA PAT 3,764 Cr 212 Cr 89 Cr +7.5 % +48.5 % +74.2% Net Turnover EBITDA Margin PAT Margin 1,464 Cr 14.3% 6.0% -1.0% +474 bps + 259 bps ⦁ Registered marginal increase in gross revenue ⦁ Discontinued some low margin BSPC business as compared to H
Slide 7: Segmental Highlights – Q2 & H1 FY24
Segmental Highlights – Q2 & H1 FY24 Figures in Rs. Cr. FY 23 FY 24 EBIT Margin Bio-Based Specialties and Potable Spirits (PS) Ennature Biopharma (EB) Performance Chemicals (BSPC) 2 5. 0% 2 5. 0% 500 3 0. 0% 25.5% 1 ,2 00 1 ,0 00 450 2 5. 0% 2 0. 0% 18.2% 2 0. 0% 400 25.2% 1 ,0 00 18.0% 800 350 2 0.
Slide 8: Highlights – Q2 & H1 FY24
Highlights – Q2 & H1 FY24 Business Performance Q2 FY24 over Q2 FY23 □ Gross Revenue at Rs. 1,870 Cr, up 14.5% YoY; Net revenue saw a growth of 15.7% at Rs. 775 Cr o BSPC Net Revenue reported a healthy growth of 14.8% YoY o PS Net Revenue saw a robust increase of 26.1% YoY □ EBITDA stood at Rs. 106 C
Slide 9: Highlights – Q2 & H1 FY24
Highlights – Q2 & H1 FY24 Other Highlights □ Grain based ethanol capacities have helped mitigate impact of ethanol cost increases □ Cost pressures continue with high international ethanol prices has been a significant headwind. However, some signs of softening in future. □ EB, commenced production o
Slide 10: Business Segment Highlights
Business Segment Highlights Bio-based Specialties and Performance Potable Spirits (PS) Ennature Biopharma (EB) Chemicals (BSPC) □ Q2 Revenue at Rs. 508 Cr., up 14.8% □ Q2 Revenue at Rs. 221 Cr., up by 26.1% □ Q2 Revenue at Rs. 46 Cr., down 11.6% □ EBIT Q2 at Rs. 42 Cr., up 46.4%, EBIT margin at □ EB
Slide 11: Financial Summary - Consolidated
Financial Summary - Consolidated Particulars (In INR Cr) Q2FY24 Q2FY23 Y-o-Y (%) Q1FY24 Q-o-Q (%) H1FY24 H1FY23 Y-o-Y (%) Revenue from operations (net of excise) 775 670 15.7% 689 12.4% 1,464 1,478 (1.0%) Other Income 11 6 6 17 12 Total Income 785 676 16.2% 695 13.0% 1,480 1,490 (0.7%) Cost of Mater
Slide 12: Financial Summary - Standalone
Financial Summary - Standalone Particulars (In INR Cr) Q2FY24 Q2FY23 Y-o-Y (%) Q1FY24 Q-o-Q (%) H1FY24 H1FY23 Y-o-Y (%) Revenue from operations (net of excise) 775 670 15.8% 688 12.7% 1,463 1,477 (1.0%) Other Income 11 8 6 17 15 Total Income 786 677 16.1% 694 13.3% 1,480 1,492 (0.9%) Cost of Materia
Slide 13: Segment Performance - Consolidated
Segment Performance - Consolidated (In INR Cr) Q2FY24 Q2FY23 % YoY Q1FY24 % QoQ H1FY24 H1FY23 Y-o-Y (%) Bio-based Specialities and Performance Chemicals (BSPC) Net Revenue 508 442 14.8% 401 26.4% 909 991 (8.3%) EBIT 42 28 46.4% 41 0.7% 83 52 58.6% % margin 8.2% 6.4% 177 bps 10.3% (210 bps) 9.1% 5.3%
Slide 14: Segmental Revenue and EBIT Mix - Consolidated
Segmental Revenue and EBIT Mix - Consolidated Revenue Mix EBIT Mix 6% 8% 8% 20% 44% 47% 66% 66% 28% 26% 45% 36% Q2FY23 Q2FY24 Q2FY23 Q2FY24 7% 7% 10% 22% 42% 62% 45% 26% 67% 31% 45% 36% H1FY24 H1FY23 H1FY24 H1FY23 BSPC PS Ennature Biopharma BSPC PS Ennature Biopharma 13
Slide 15: Company Overview
Company Overview INDIA GLYCOLS LIMITED 14
Slide 16: IGL at a Glance
IGL at a Glance Go Green Diversified product portfolio Global Standards with inherent synergies Compliance with stringent global 1st in the world to use Innovative Green Technologies to manufacture Bio-based Specialties, Bio-Polymers, standards of plant operations, bio-based ethylene oxide & Potable
Slide 17: Key Milestones
Key Milestones New Grain based Formulatio Ethanol plant – Gorakhpur n Gorakhpur & Distillery & Sulphation Kashipur First EO Glycol E2 Thiocolchicosi Distille Purificat Bio Polymers | Textile US JV MEG 600 de Nicotine ry ion Green Solvents ENA Subsidiar Clariant TPD Expansion y 1988 1990 1994 1996 20
Slide 18: Portfolio Leading in Bio-based Ingredients and Performance Chemicals
Portfolio Leading in Bio-based Ingredients and Performance Chemicals Bio-based Specialities Segments And Performance Potable Spirits (PS) Ennature Biopharma Chemicals (BSPC) Revenue Mix Net revenue share 64% Net revenue share 28% Net revenue share 7% (Consol. FY23) □ Bio-based Glycols (MEG, DEG, TEG
Slide 19: JV with Clariant: Leaders in bio-based ethoxylates and derivatives
JV with Clariant: Leaders in in bio-based ethoxylates and derivatives Promoters Public 1 - Shareholding Combining production and distribution capacity, as 61.01% 1 38.99% 1 on 30th June 2021 the joint venture is establishing to become a leading supplier of renewable materials to the rapidly growing
Slide 20: Leveraging synergies to create value–integrated manufacturing
Leveraging synergies to create value–integrated manufacturing for bio-based products Portable Spirits (PS) Products Potable Spirit Industrial Gas ENA Power Alcohol O2, N2, Ar Brands Division Ind Gr. CO2 Grain O2 ASU EO-CO2 mix Business transferred to JV with Clariant Bio-based Specialities Green And
Slide 21: Manufacturing Capabilities
Manufacturing Capabilities Kashipur Gorakhpur Dehradun 300-acre state of art integrated manufacturing complex 56-acre state of art distillation & bottling complex 160,000 sqft state of art facility Fermentation – Molasses and Grain Based Grain based Ethanol High Purity Extraction Ethanol Distillatio
Slide 22: R&D: Creating value through New Product Development
R&D: Creating value through New Product Development; focus on Green Chemistry 1 Focus on NPD, designing products for the future in collaboration with our reputed customers 2 DSIR Recognized R&D at Dehradun and Kashipur 3 Exploiting available feed stocks of Bio-Alcohol, Smart Alcohol, Ethylene Oxide,
Slide 23: Business Segments
Business Segments INDIA GLYCOLS LIMITED 5
Slide 24: Bio-based Specialities and Performance Chemicals (BSPC)
Bio-based Specialities and Performance Chemicals (BSPC) First in the world to manufacture ethylene oxide and glycols from bio-based feedstocks e.g. Molasses, Grain Largest manufacturer of Bio-based glycols and Bio-based Ethylene Oxide made from renewable feedstock i.e. Molasses Products for a
Slide 25: Potable Spirits (PS)
Potable Spirits (PS) License for operations and sale of Country Liquor in the States of Uttar Pradesh and Uttarakhand. Also operates and sells Indian Made Foreign Liquor (“IMFL”) from its own unit and few tie-up units Company brands are available in the states of Uttarakhand, Uttar Pradesh, Delh
Slide 26: Ennature Biopharma (EB)
Ennature Biopharma (EB) Operates in the space of Nutraceuticals, Phytochemicals & health supplement ingredients. One of the leaders in Complex phytochemicals chemistry in India Global leader in Thiocolchicoside, a highly potent muscle relaxant API Advanced production capabilities, including or
Slide 27: IGL - Catering to diverse end markets
IGL - Catering to diverse end markets • Glycols are used for the manufacture of polyester yarn, fibre, film and resin and as an automobile coolant • Bio-glycols cater to the beverage and food industry's packaging requirement of PET bottles and polyester film • Ethyl / Butyl glycol ethers and its ace
Slide 28: Growth Drivers
Growth Drivers 27
Slide 29: Growth Drivers
Growth Drivers High prospects of growth of industry sectors being serviced by IGL – Personal Care, Automotive, Packaging, Beverages, Oil & Gas, Home Care, Pharma, Nutraceuticals etc, Textiles – most expected to grow at near double digit or more Increasing consumer awareness and demand for sustai
Slide 30: Yearly financial Performance
Yearly financial Performance 29
Slide 31: 4-year Financial Trajectory - Consolidated
4-year Financial Trajectory - Consolidated In INR Net Revenue (Excl. EBITDA (Excl. Discontinued PAT (Excl. Discontinued Biz.) Cr Discontinued Biz.) Biz.) 330 319 2,744 2,890 288 283 277 2,675 2,332 141 109 75 FY2020 FY2021 FY2022 FY2023 FY2020 FY2021 FY2022 FY2023 FY2020 FY2021 FY2022 FY2023 Net Rev
Slide 32: 4-year Financial Trajectory - Consolidated
4-year Financial Trajectory - Consolidated EBITDA Margin (%) (Excl. PAT Margin (%) (Excl. Discontinued RoE (%) Discontinued Biz.) Biz.) 11.4% 12.1% 11.9% 10.5% 19.2% 9.6% 5.3% 11.1% 11.3% 4.7% 7.4% 2.7% FY2020 FY2021 FY2022 FY2023 FY2020 FY2021 FY2022 FY2023 FY2020 FY2021 FY2022 FY2023 EBITDA Margin
Slide 33: Sustainability, ESG and Certifications
Sustainability, ECG and Certifications
Slide 34: Sustainability, ESG
Sustainability, ESG Environment Stewardship • World’s first and largest producer of Bio-Based EO and its derivatives • Next Generation CarbonSmart products from emissions (fossil carbon) - collaboration with Transparent Accountable LanzaTech & consumer majors like Unilever and Lululemon • Environmen
Slide 35: Thank you
Thank you Ernst & Young LLP India Glycols Limited CIN: L24111UR1983PLC009097 Runjhun Jain Ankur Jain runjhun.jain1@in.ey.com Company Secretary & Compliance Officer Head office Rohit Anand rohit.anand4@in.ey.com 2B, Sector-126, Noida Tel: +91-120-6860000, 3090100, 3090200 Gautam Budh Nagar Fax: +91-1
India Glycols — Q2 & H1 FY2023-24 Earnings Presentation on 6ix